Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
University of Florida · NCT02368041
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 25 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 130
- US sites recruiting
- 1
- Study start
- May 2015
- Record last updated
- March 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a single-center, non-randomized study.The study staff will use the InSpectraTM tissue oxygen saturation (StO2) monitor manufactured by Hutchinson Technology to measure baseline StO2 levels after applying the noninvasive probe to the thenar eminence. After a stable reading is obtained, a blood pressure cuff will be inflated 40 mmHg above the obtained systolic pressure and the rate of desaturation (Rdes; % × sec-1) will be recorded. After 3 minutes or once the StO2 level comes to zero (whichever is earlier), the cuff pressure will be released and the rate of reperfusion (Rres; % × sec-1) will be measured. The investigators hypothesize that heart failure in children causes a baseline lower thenar tissue oxygen saturation (StO2), a faster rate of desaturation (Rdes) and a prolonged rate of reperfusion (Rres). The investigators also hypothesize that these changes will correlate with the severity of heart failure. The results of this study will provide groundwork for studies looking at correlation of therapy modification based on the combination thenar StO2 and clinical presentation.
Being studied: InSpectraTM StO2 monitor
Conditions: Heart Failure
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Heart failure patients under 25 years of age with a diagnosis of cardiomyopathy, myocarditis or univentricular palliation for congenital heart disease who are stable on their medical management will be enrolled.
Exclusion Criteria
- Patients presenting with acute deterioration in clinical status
- Patients with active infection
- Patients with autoimmune vasculitis disorder
- Patients with limb deformities and painful disorders of extremities
- Patients with underlying bone disorders, (e.g. osteogenesis imperfecta)
- Patients with severe anemia (Hb \<7g/dL)
- Patients with peripheral vascular disease which can alter the microcirculation
Recruiting US locations
University of Florida
Gainesville, FL 32610
Site contact: Dipankar Gupta, MD · 352-273-7770 · dgupta@ufl.edu
Study contacts (from the official record)
- Dipankar Gupta, MD · 352-273-7770 · dgupta@ufl.edu
Similar studies in Florida
All heart & blood pressure studies in Florida →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Orlando, FL + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
Shanghai CureGene Pharmaceutical Co., Ltd.
- Location
- Miami, FL
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Novartis Pharmaceuticals
- Location
- Bradenton, FL + 4 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Clearwater, FL + 30 other US sites
- Eligibility basics
- Ages 65+